Amgen Inc (AMGN)

206.35 +8.08  +4.08% NASDAQ Mar 30, 13:28 Delayed 2m USD
View Full Chart
Price Chart
View All Events

Events

Date Type Description
05/15/2020 Dividends Amount: 1.60, Declared Date: Mar 04 2020, Pay Date: Jun 08 2020
04/30/2020 17:00 EDT Misc Amgen Inc First Quarter Earnings Conference Call in 2020
04/30/2020 Earnings Amgen Inc First Quarter Earnings in 2020 Release
02/13/2020 Dividends Amount: 1.60, Declared Date: Dec 11 2019, Pay Date: Mar 06 2020
02/12/2020 Misc Amgen Inc Annual Report for 2019
01/30/2020 17:00 EST Misc Amgen Inc Fourth Quarter Earnings Conference Call for 2019
01/30/2020 Earnings Amgen Inc Fourth Quarter Earnings in 2019 Release
11/14/2019 Dividends Amount: 1.45, Declared Date: Oct 22 2019, Pay Date: Dec 06 2019
10/29/2019 14:00 PDT Misc Amgen Inc Third Quarter Earnings Conference Call for 2019
10/29/2019 Earnings Amgen Inc Third Quarter Earnings in 2019 Release
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • URL: https://www.amgen.com
  • Investor Relations URL: http://investors.amgen.com/phoenix.zhtml?c=61656&p=irol-IRHome
  • HQ State/Province: California
  • Sector: Healthcare
  • Industry: Drug Manufacturers - General
  • Equity Style: Large Cap/Blend
  • Next Earnings Release: Apr. 30, 2020
  • Last Earnings Release: Jan. 30, 2020
  • Next Ex-Dividend Date: May. 15, 2020
  • Last Ex-Dividend Date: Feb. 13, 2020
  • Description: Amgen is a leader in biotechnology-based human therapeutics, with historical expertise in renal disease and cancer supportive-care products. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and received approval for bone-strengthening drug Prolia/Xgeva in 2010. Amgen's acquisition of Onyx bolstered the firm's therapeutic oncology portfolio with Nexavar and Kyprolis. Recent launches include Repatha (cholesterol-lowering) and Aimovig (migraine).

Top Fund Holders

Symbol Name Weighting
IBB iShares Nasdaq Biotechnology ETF 7.60%
XLV Health Care Select Sector SPDR® ETF 3.72%
VPMCX Vanguard PRIMECAP Inv 3.62%
VHT Vanguard Health Care ETF 2.91%
RMEBX American Funds American Mutual R2E 2.35%
RIBEX American Funds Invmt Co of Amer R2E 1.83%
RCEEX American Funds Capital Income Bldr R2E 1.82%
QQQ Invesco QQQ Trust 1.53%
VYM Vanguard High Dividend Yield ETF 1.26%
CWGCX American Funds Capital World Gr&Inc C 1.20%
IWF iShares Russell 1000 Growth ETF 0.81%

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.